Evidence map›Paper›PMID 34577638›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Preparation of Soluble Complex of Curcumin for the Potential Antagonistic Effects on Human Colorectal Adenocarcinoma Cells.

Jamal Moideen Muthu Mohamed, Ali Alqahtani, Barkat A Khan, Adel Al Fatease, Taha Alqahtani, Krishnaraju Venkatesan, Fazil Ahmad, Bashar I Alzghoul, Ali Alamri

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Application of 3Scientific reports · 2024
    Article
  2. Article
  3. Polymeric ethosomal gel loaded with nimodipine: Optimisation, pharmacokinetic and histopathological analysis.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  4. FeProgress in biomaterials · 2022
    Article
  5. Article
  6. Curcumin Plant for Colorectal Cancer Prediction and Prevention UsingEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  7. Article
  8. Article
  9. Development of Atorvastatin Calcium Biloaded Capsules for Oral Administration of Hypercholesterolemia.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jamal Moideen Muthu MohamedCollege of Pharmacy, Shri Indra Ganesan Institute of Medical Science, Tiruchirappalli 620012, Tamil Nadu, India.ORCID 0000-0001-6362-8629
Ali AlqahtaniDepartment of Pharmacology, College of Pharmacy, King Khalid University, Guraiger, Abha 62529, Saudi Arabia.ORCID 0000-0002-2240-4757
Barkat A KhanDrug Delivery and Cosmetics Lab (DDCL), GCPS, Faculty of Pharmacy, Gomal University, Dera Ismail Khan 29050, Pakistan.ORCID 0000-0003-4920-1770
Adel Al FateaseDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Guraiger, Abha 62529, Saudi Arabia.ORCID 0000-0002-4608-5949
Taha AlqahtaniDepartment of Pharmacology, College of Pharmacy, King Khalid University, Guraiger, Abha 62529, Saudi Arabia.ORCID 0000-0003-4017-8754
Krishnaraju VenkatesanDepartment of Pharmacology, College of Pharmacy, King Khalid University, Guraiger, Abha 62529, Saudi Arabia.ORCID 0000-0003-2853-5907
Fazil AhmadDepartment of Anesthesia Technology, College of Applied Medical Sciences in Jubail, Imam Abdulrahman Bin Faisal University, P.O. Box 4030, Jubail 35816, Saudi Arabia.
Bashar I AlzghoulRespiratory Care Department, College of Applied Medical Sciences in Jubail, Imam Abdulrahman Bin Faisal University, Dammam, Jubail 35816, Saudi Arabia.
Ali AlamriDepartment of Pharmaceutics, College of Pharmacy, King Khalid University, Guraiger, Abha 62529, Saudi Arabia.ORCID 0000-0001-6790-2226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to investigate the effects of curcumin (CMN) soluble complex (SC) prepared by melt casting (HM) and hot-melt extrusion (HME) technology. Phase solubility (PS) study, in silico molecular modeling, aqueous solubility, drug release, and physicochemical investigation including a novel dyeing test was performed to obtain an optimized complex by a central composite design (CCD). The results show that the HME-SC produces better improvements towards solubility (0.852 ± 0.02), dissolution (91.87 ± 0.21% at 30 min), with an ideal stability constant (309 and 377 M

Indexed as

central composite designcolorectal cancercurcuminhot-melt extrusionin silico molecular studyphase solubility study

Identifiers

PMID34577638
PMCPMC8467777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.